Status:
WITHDRAWN
Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Conditions:
Infant, Premature
Anticoagulants
Eligibility:
All Genders
Up to 1 years
Phase:
NA
Brief Summary
Background: Heparin is an anticoagulant commonly used in the neonatal population as a means to prevent catheter related occlusion and malfunction by thrombosis (clot). Given the recent overdoses of in...
Eligibility Criteria
Inclusion
- Neonates admitted to the Neonatal Intensive Care Unit (NICU) at University Hospital in San Antonio, Texas who require a percutaneous central venous catheter, as determined by the attending neonatologist.
Exclusion
- Evidence of bleeding (prolonged aPTT)
- Recent sepsis (w/in 48 hours of initiation of antimicrobial therapy)
- Propensity for stroke or thrombophilia
- Requiring heparinization (i.e. dialysis)
- Discretion of the neonatologist (severe illness to the point of uncertain viability, poor intravenous access requiring surgical placement of a long term intravenous catheter e.g. Broviac)
- Requirement of a 1 French catheter
- Uncertain viability (this is based on the discretion of the infant's neonatologist who is not a member of the research team)
- Nonviable neonates (this is based on the discretion of the infant's neonatologist who is not a member of the research team)
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00879957
Start Date
January 1 2010
End Date
May 1 2011
Last Update
April 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
San Antonio, Texas, United States, 78229